world of tanks power leveling - DYC

Xinhua News Agency,, March 6 (reporter Ren Haijun)-due to acute promyelocytic leukemia in original results obtained in the research and development of new therapies, Chinese Academy of engineering Academician Wang Zhenyi and Chen, academician of CAs, 6th in the United States receive the seventh award by the National Foundation for cancer research Szentgyorgy innovation achievement award for cancer research. Trioxide two scientistsArsenic (commonly known as arsenic) combined with Western medicine for the treatment of leukemia, so that patients with acute promyelocytic leukemia "five-year disease-free survival rates" jumped from about 25% to about 95%. 　　This combination therapy is currently the worldwide standard therapy for acute promyelocytic leukemia. "Szentgyorgy the award is cancer research breakthrough, this breakthrough is the new cancersBreakthroughs in therapy possible; was to millions of breakthrough brings hope for cancer can be cured, "America's Cancer Research Foundation President Franklin · Xiao Borui said at the award ceremony," two scientists make such breakthroughs. "Chen says, cancer prevention, control, and treatment is an area full of challenge, of much-needed research breakthroughs, conquer whiteBlood disease has always been his dream, winning is the result of teamwork as well as the ongoing efforts of several generations. Leukemia is commonly known as "blood" wot power leveling, acute promyelocytic leukemia, is the most dangerous, of course the fastest "leukemia". In the 80 's, Wang Zhenyi Shanghai Ruijin hospital conducting clinical work first of all-TRANS Retinoic acid on acute promyelocytic cellsTreatment of Leukemia patients, making their survival rate has improved significantly. Subsequently world of tanks power leveling, the student Chen Zhu, further clinical trials of Wang Zhenyi, verified as arsenic in traditional Chinese medicine for treatment of patients with acute promyelocytic leukemia is valid. In the late 90 's, two scientists on the joint use of all-TRANS Retinoic acid and arsenic treatment of Leukemia patients in clinical trials, efficiencyFruits significantly. 　　Wang Zhenyi and Chen Zhu, will share a $ 25,000 bonus. Wang Zhenyi is now a tenured professor world of tanks power leveling, Faculty of Medicine of Shanghai Jiao Tong University, Shanghai honorary Director of the national heart, lung and Blood Institute, France Academy of Sciences foreign members. He has served as Chen graduate student mentors. Minister of the Chinese Ministry of health Chen Zhu, is also a member of the third World Academy of Sciences and the European Academy of Sciences, United States Academy of SciencesAnd the France Academy of Sciences and the United States foreign members of the Academy. National Foundation for cancer research was founded in 1973, is the United States largest public agency for research on cancer, Szentgyorgy set up its innovation awards are designed to reward for cancer research cancer research has made remarkable contributions to create a scientist. (Final) (Editor: Enami)